At the recent MD&M West exhibition, Sabic’s Innovative Plastics business introduced new tools to help medical device manufacturers reduce healthcare associated infections (HCAIs) among patients and clinicians. The company’s nine new antimicrobial compounds featuring silver technology have been tested for log reduction values, the level of microbes eliminated from a surface according to the ISO 22196-2007 protocol. These compounds leverage silver-based antimicrobial technology because silver is a proven performer, well suited to diverse applications and widely accepted as a broad-spectrum antimicrobial, with activity against many pathogens including gram-positive and gram-negative bacteria, mold and fungus
Sabic’s portfolio comprises nine different antimicrobial grades across four product families: Lexan EXL copolymer, Lexan polycarbonate (PC) resin, Xenoy PC/polybutylene terephthalate (PBT) resin and polypropylene (PP) resins with and without fiberglass reinforcement. Five grades have a high antimicrobial effect (log reduction value above 4, representing a 99.99+ percent reduction in pathogens) and four grades have a low antimicrobial effect (log reduction value below 4, representing a 99.0-99.99 percent reduction in pathogens). These options allow customers to select the appropriate formulation depending on whether the end product is a high or low-touch application.
www.sabic-ip.com
